These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28028642)

  • 1. Nanomedicine in brain repair: Alzheimer's, Parkinson's and the proteome.
    Broderick PA; Jacoby JH
    J Neural Transm (Vienna); 2017 Jan; 124(1):1. PubMed ID: 28028642
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
    Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
    Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases.
    Montine TJ; Montine KS
    J Exp Med; 2015 May; 212(5):601-5. PubMed ID: 25941321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Obesity, Alzheimer's Disease, and Parkinson's Disease: an Astrocentric View.
    Martin-Jiménez CA; Gaitán-Vaca DM; Echeverria V; González J; Barreto GE
    Mol Neurobiol; 2017 Nov; 54(9):7096-7115. PubMed ID: 27796748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease.
    Korecka JA; Verhaagen J; Hol EM
    Regen Med; 2007 Jul; 2(4):425-46. PubMed ID: 17635050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep brain stimulation shows promise for Alzheimer's, depression treatment. Doctors also now have more options in how DBS is used to treat Parkinson's disease.
    Duke Med Health News; 2010 Nov; 16(11):1-2. PubMed ID: 21186495
    [No Abstract]   [Full Text] [Related]  

  • 7. The spectrum series: grappling with the overlap between Alzheimer's and Parkinson's diseases. 9th International Conference on Alzheimer's and Parkinson's Diseases, 11-15 March 2009, Prague,Czech Republic.
    Strobel G
    J Alzheimers Dis; 2009; 18(3):625-40. PubMed ID: 19749400
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuropathological hallmarks of Alzheimer's and Parkinson's diseases.
    Braak H; de Vos RA; Jansen EN; Bratzke H; Braak E
    Prog Brain Res; 1998; 117():267-85. PubMed ID: 9932414
    [No Abstract]   [Full Text] [Related]  

  • 9. Human cloning recommended for therapeutic research holds promise for treating Parkinson's and Alzheimer's diseases.
    J Am Geriatr Soc; 1999 Mar; 47(3):369. PubMed ID: 10078903
    [No Abstract]   [Full Text] [Related]  

  • 10. Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies.
    Ciceri F; Rotllant D; Maes T
    Curr Pharm Des; 2017; 23(5):839-857. PubMed ID: 28120717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal filaments in Alzheimer's, Pick's, and Parkinson's diseases.
    Kahn J; Anderton BH; Gibb WR; Lees AJ; Wells FR; Marsden CD
    N Engl J Med; 1985 Aug; 313(8):520-1. PubMed ID: 4040609
    [No Abstract]   [Full Text] [Related]  

  • 12. [Parkinson's disease accompanied by dementia--a case of concurrent Parkinson's and Alzheimer's diseases (author's transl)].
    Sugimura K; Yamasaki Y; Ando K
    Rinsho Shinkeigaku; 1977 Aug; 17(8):513-9. PubMed ID: 923169
    [No Abstract]   [Full Text] [Related]  

  • 13. Inside SMP proteomics: six years German Human Brain Proteome Project (HBPP) - a summary.
    Hamacher M; Hardt T; van Hall A; Stephan C; Marcus K; Meyer HE
    Proteomics; 2008 Mar; 8(6):1118-28. PubMed ID: 18283670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamines and protein deposition in Parkinson's and Alzheimer's disease: old medicine, new targets.
    Bharath S; Andersen JK
    Rejuvenation Res; 2004; 7(2):92-4. PubMed ID: 15312295
    [No Abstract]   [Full Text] [Related]  

  • 15. Association Between Pathology and Electroencephalographic Activity in Parkinson's Disease.
    Caviness JN; Beach TG; Hentz JG; Shill HA; Driver-Dunckley ED; Adler CH
    Clin EEG Neurosci; 2018 Sep; 49(5):321-327. PubMed ID: 29161906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances on the Role of Neurogenesis in the Adult Brain: Therapeutic Potential in Parkinson's and Alzheimer's Diseases.
    Radad K; Moldzio R; Al-Shraim M; Kranner B; Krewenka C; Rausch WD
    CNS Neurol Disord Drug Targets; 2017; 16(7):740-748. PubMed ID: 28641510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    Belaidi AA; Bush AI
    J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is leuko-araiosis in Alzheimer's disease, in Parkinson's disease and in healthy elderly persons the result of Wallerian degeneration?].
    Leys D; Pruvo JP; Soetaert G; Vermersch P; Rapoport A; Clarisse J; Petit H
    Acta Neurol Belg; 1989; 89(3-4):249-52. PubMed ID: 2516973
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene therapy for Parkinson's and Alzheimer's diseases: from the bench to clinical trials.
    Nobre RJ; Almeida LP
    Curr Pharm Des; 2011; 17(31):3434-45. PubMed ID: 21902665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's and Parkinson's diseases: an environmental proteomic point of view.
    Demartini DR; Schilling LP; da Costa JC; Carlini CR
    J Proteomics; 2014 Jun; 104():24-36. PubMed ID: 24751585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.